Loading news...
Shares of Alphatec Holdings, Inc. (NASDAQ: ATEC - Get Free Report) have been given an average recommendation of "Moderate Buy" by the twelve analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and ten have issued a buy
Emerald Advisers LLC lessened its stake in Alphatec Holdings, Inc. (NASDAQ: ATEC) by 2.7% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,638,882 shares of the medical technology company's stock after selling 45,452 shares during the quarter. Emerald Advisers
Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Craig E. Hunsaker, EVP, People & Culture at Alphatec Holdings, sold 32,584 shares for a transaction value of $679,050.56 at $20.84 per share on Dec. 10, 2025. The sale represented 2.53% of Hunsaker's direct holdings, reducing his stake from 1,289,142 to 1,256,558 shares.
Alphatec Holdings, Inc. (ATEC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
ATEC Secures Exclusive U.S. Rights to OsteoAdapt® Platform in Major Strategic Alignment Theradaptive Initiates Series B to Advance Proprietary Protein-Engineering Technology CARLSBAD, Calif. and FREDERICK, Md.
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary financial results for the fourth quarter and full-year ended December 31, 2025. The Company also provided a financial outlook for full-year 2026. Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Select Financial Results Fourth Quarter Ended December 31, 2025 Full Year Ended De.
Miles Patrick, the CEO of Alphatec Holdings, sold 100,000 shares of the company for about $2.1 million, according to a recent Form 4. This sale represented 1.82% of Miles Patrick's direct holdings, reducing direct ownership to 5.14 million shares.
Alphatec Holdings, Inc. (NASDAQ: ATEC - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $15.75 and traded as high as $21.20. Alphatec shares last traded at $20.98, with a volume of 1,149,093 shares traded. Analysts Set
COO Scott Lish sold 19,900 shares for a transaction value of $390,836 on Dec. 16, 2025. The sale reduced direct ownership to 641,432 shares (0.43% of shares outstanding).
Alphatec Holdings, Inc. (NASDAQ: ATEC - Get Free Report) EVP David Sponsel sold 21,106 shares of the business's stock in a transaction dated Wednesday, December 10th. The stock was sold at an average price of $20.79, for a total value of $438,793.74. Following the transaction, the executive vice president directly owned 439,767 shares of the company's
Pre-Market Stock Futures: Futures are trading lower after a big rate-cut rally on Wednesday was sideswiped by Oracle's disappointing earnings after the bell yesterday. The Federal Reserve's 25-basis-point rate cut, as expected, put the benchmark rate at 3.50%-3.75%. The third consecutive cut lowered rates to their lowest level since late 2022, to help support a... Here Are Thursday's Top Wall Street Analyst Research Calls: American Eagle Outfitters, Ferrari, Intuitive Surgical, Roku, PayPal, Synopsis, Visa, and More.
Alphatec stock is up 118% year to date on quarterly results that beat expectations. Although currently unprofitable, the company is expecting full-year positive free cash flow in 2025.
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC) (“ATEC”), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced with great sadness that Jeffrey P. Rydin, a valued member of its Board of Directors, has passed away at age 59, following a lengthy illness. Mr. Rydin enjoyed nearly three decades of experience in the medical device and healthcare industries, including senior sales leadership roles at Ellipse Technologi.
Alphatec Holdings, Inc. ( ATEC ) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Patrick Miles - Executive Chairman, CEO & President J. Koning - Executive VP & CFO Conference Call Participants Vikramjeet Chopra - Wells Fargo Securities, LLC, Research Division Matthew Miksic - Barclays Bank PLC, Research Division Young Li - Jefferies LLC, Research Division Anna Runci - Piper Sandler & Co., Research Division K.
Alphatec (ATEC) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to a loss of $0.28 per share a year ago.
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2025, and recent corporate highlights. Third Quarter 2025 Financial Results Quarter Ended September 30, 2025 Total revenue $197 million GAAP gross margin 70% Non-GAAP gross margin 70% GAAP operating expenses $153 million Non-GAAP operating exp.
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2025 financial results on October 30, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations section of ATEC's corporate website. Dial-In To dial into the.
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences: The 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 12, 2025. The RBCCM Medical Supplies & Devices Virtual Symposium virtually on August 18, 2025, from 10:00am – 11:00am ET. The Piper Sandler MedTech and Di.
While the broader stock market suffered steep losses on Friday amid trade policy shifts and troubling economic data, select health technology equities stood out.